Cryoport
CYRX | NASDAQ
$19.80
-$0.09 (-0.45%)
At close: Nov 16, 2026, 4:00 PM ET
$19.80
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-0.45%
(1D)No price chart data available for 1D timeframe.
Rating
43.5
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #525/882 (Top 60%)
Key Statistics
Market Data
Market Cap $1B
1D Range
19.49 20.06
52W Range
7.72 20.74
Valuation (TTM)
PE -22.25
PB 2.07
EV/EBITDA -68.16
Valuation (NTM)
Forward PE N/A
Forward PEG 0.14
Price Target $20.50
Cash Flow
FCF Yield -1.8%
SBC Adj. FCF Yield -2.8%
SBC Impact -52.4%
Margins
Gross Margin 46.9%
Operating Margin -20.0%
FCF Margin -9.5%
Growth (CAGR)
Revenue 3Y | 5Y -6.6% |
-2.1%
Dil EPS 3Y | 5Y 120.5% |
61.8%
FCF 3Y | 5Y 25.6% |
8.2%
Returns
ROA -5.3%
ROE -8.2%
ROIC -5.4%
Financial Health
Net Cash
$161.57M
Current Ratio 2.04
Interest Coverage -18.32
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Cryoport, Inc. operates as a specialized service provider within the life sciences sector, delivering global temperature-controlled supply chain solutions across the Americas, Europe, the Middle East,...
Sector Industrials
Industry Integrated Freight & Logistics
Employees 688
IPO Date Aug 22, 2005
Website www.cryoportinc.com
Fiscal Year January - December
Latest News
7 days ago · seekingalpha.com
Cryoport Needs To Chill Down (Downgrade)Cryoport, Inc. is downgraded from Hold to Sell due to valuation concerns despite strong revenue growth. CYRX's balance sheet improved after the CRYOPDP sale, with net cash of $204.8 million, but profitability remains elusive. Revenue outperformed forecasts, driven by Life Sciences Services and commercial cell/gene therapy, yet net losses widened and margins remain weak.
Earnings
Latest Earnings
Nov 5, 2026
EPS
-$0.25
Miss -41.36%
YoY:
-38.89% REV
$50.22M
Beat +3.20%
YoY:
+13.54%Next Earnings
Mar 2, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
5
Consensus
Buy
Price Target
$20.50
Upside
+3.54%
Buy (5)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove CYRX